WuXi Biologics 2 may 2026 WuXi Biologics Advances Global Sustainability Strategy With 2025 ESG Report - BioPharma APAC
WuXi Biologics 1 may 2026 Is WuXi Biologics (SEHK:2269) Attractive After Its Five Year Share Price Reset? - simplywall.st
WuXi Biologics 25 abr 2026 WuXi Biologics Secures MFDS GMP Certification For Three Key Manufacturing Facilities - BioPharma APAC
WuXi Biologics 24 abr 2026 WuXi Biologics Secures MFDS GMP Certification For Three Key Manufacturing Facilities - BioPharma APAC
WuXi Biologics 24 abr 2026 WuXi Biologics Completes Structure of Chengdu Microbial Manufacturing Site - Contract Pharma
WuXi Biologics 12 mar 2026 WuXi Biologics Wins Multiple Asia-Pacific Biopharma Excellence Awards for Leadership in Bioprocessing, Manufacturing Excellence, and Digital Innovation - PR Newswire
WuXi Biologics 27 feb 2026 Earendil pens $885M pact to use WuXi XDC's linker tech for next-gen ADCs - Fierce Biotech